T-Cell Specific Surface Glycoprotein CD28 Market Booming Worldwide with Latest Trend and Future Scope by 2029

T-cell specific surface glycoprotein CD28 market is anticipated to grow at a significant CAGR during the forecast period. CD28 is a glycoprotein of 90 kDa and occurs naturally as a disulfide-linked homodimer of a polypeptide that contains a single Ig-like extracellular domain. Additionally, it is a member of the Ig superfamily and is expressed on T cells that provide co-stimulatory signals which are required for T cell activation and survival. Furthermore, it acts as a major costimulation pathway for naive T-cell activation while playing a central role in immune responses against pathogens, autoimmune diseases, and graft rejection.

Moreover, it enhances the production of IL4 and IL10 in T-cells in conjunction. Additionally, it signals the initial activation of naive CD4 T cells by increasing the sensitivity of the T cell to antigen receptor engagement. Furthermore, CD28 is expressed on 50% of CD8+ T cells and more than 80% CD4+ T cells in humans and supports to kill cancer cells that are virally infected or that are under damage. Hence, the factor driving the growth of the market is the prevalence of cancer.

According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US in 2020. Furthermore, there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. Some major players in the market include Bristol-Myers Squibb Co., and Johnson and Johnson Services, Inc., among others. 

To Request a Sample of our Report on T-Cell Specific Surface Glycoprotein CD28 Market:  https://www.omrglobal.com/request-sample/t-cell-specific-surface-glycoprotein-cd28-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030

Segment Covered- 

By Type
By Application

Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- Amgen Inc., and Johnson & Johnson Services, Inc., among others. 

T-Cell Specific Surface Glycoprotein CD28 Market Report by Segment

By Type

FPT-155
FR-104
Lulizumab Pegol
Others

By Application 

Plaque Psoriasis
Solid Tumor
Acute Renal Failiure(ARF)
Others

A full Report of T-Cell Specific Surface Glycoprotein CD28 Market is Available @ https://www.omrglobal.com/industry-reports/t-cell-specific-surface-glycoprotein-cd28-market

 T-Cell Specific Surface Glycoprotein CD28 Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.